The Washington Pregnancy Biorepository is a research study within the University of Washington Maternal-Fetal Medicine Research Division. By collecting biological samples and health information from pregnant individuals, researchers are working to improve our understanding of pregnancy and develop new ways to improve care for pregnant...
This study investigates brain response differences in fear learning in adult women at different phases of their menstrual cycle, in both healthy control and OCD groups. This is an in-person study located at Kincaid Hall at the University of Washington. This study will last approximately 3-4...
The Brain Influences on growth at Birth Study is trying to learn how the baby brain and nutrition contributes to weight gain and growth early in life in babies of mothers who experienced gestational diabetes....
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] The CUB study is currently recruiting pregnant individuals who have either used or not used cannabis during their pregnancy. Participants can earn $700 or more for completing six visits throughout pregnancy and through their child’s first 18 months of...
This study examines how pregnant and non-pregnant women make decisions during common daily activities and tasks, like carrying objects. We want to determine if factors of physical and mental load influence these decisions differently between these groups. Participants will be asked to attend one, 50-60...
An active lifestyle improves outcomes for women with breast cancer. The ACE Study, funded by the Breast Cancer Research Foundation, will investigate how a 45-minute bout of moderate exercise can affect the biology of the human body. This could help explain the influence of physical...
To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo. To determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo. To assess self-report of depressive symptoms To evaluate the safety and tolerability of SAGE-217 This is a PHASE 3...
The purpose of this study is to better understand how exposure to the hormones estradiol and cortisol influence the body’s processing of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. THC use is increasingly common among pregnant women, and it is not known how exposure...
Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.
